VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VVOS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VVOSVivos Therapeutics, Inc.
$0.47$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVVOSQuarterly Financials

Vivos Therapeutics, Inc. (VVOS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Vivos Therapeutics, Inc. (VVOS) quarterly income statement — complete revenue, gross profit & net income history

VVOS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue5.14M3.82M6.78M3.82M3.02M3.7M3.86M4.05M3.42M3.25M3.3M3.4M3.86M3.95M4.25M4.18M3.64M4.39M4.55M4.5M
Revenue Growth %70.46%3.41%75.73%-5.77%-11.79%13.85%16.93%19.41%-11.36%-17.77%-22.26%-18.86%5.85%-10.11%-6.6%-6.96%5.68%32.88%38.11%37.47%
Cost of Goods Sold2.54M836K2.85M1.71M1.51M1.6M1.53M1.4M1.48M1.31M1.55M1.3M1.52M1.57M1.75M1.6M1.09M1.29M1.36M873K
COGS % of Revenue49.33%21.86%41.96%44.76%49.97%43.29%39.53%34.61%43.35%40.33%47.08%38.2%39.41%39.65%41.22%38.15%29.99%29.29%29.98%19.41%
Gross Profit2.6M2.99M3.94M2.11M1.51M2.1M2.33M2.65M1.94M1.94M1.75M2.1M2.34M2.38M2.5M2.59M2.55M3.11M3.18M3.62M
Gross Margin %50.67%78.14%58.04%55.24%50.03%56.71%60.47%65.39%56.65%59.67%52.92%61.8%60.59%60.35%58.78%61.85%70.01%70.71%70.02%80.59%
Gross Profit Growth %72.63%42.49%68.68%-20.41%-22.1%8.2%33.6%26.36%-17.12%-18.71%-30.01%-18.93%-8.39%-23.28%-21.58%-28.59%-5.17%15.6%23.26%32.93%
Operating Expenses9.22M9.37M8.67M6.97M5.43M4.9M4.98M4.59M5.72M6.22M5.39M6.62M7.34M8.45M7.9M9.55M9.19M10.52M8.69M7.68M
OpEx % of Revenue179.34%245.03%127.83%182.59%179.94%132.59%128.99%113.15%167.36%191.56%163.19%194.85%190.36%213.85%186.13%228.3%252.2%239.36%191.07%170.89%
Selling, General & Admin9.22M8.93M8.29M6.67M5.25M4.76M4.83M4.44M5.58M6.07M5.24M6.47M7.17M8.28M7.73M9.39M9.03M9.44M8.49M7.49M
SG&A % of Revenue179.34%233.47%122.17%174.58%174.07%128.69%125.21%109.57%163.09%186.98%158.65%190.49%185.82%209.57%182.01%224.43%247.75%214.8%186.82%166.56%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses0442K384K306K177K144K146K145K146K149K150K148K175K169K175K162K162K1000K193K195K
Operating Income-6.62M-6.38M-4.73M-4.87M-3.92M-2.81M-2.65M-1.94M-3.79M-4.28M-3.64M-4.52M-5M-6.06M-5.41M-6.96M-6.64M-7.41M-5.5M-4.06M
Operating Margin %-128.67%-166.89%-69.79%-127.36%-129.91%-75.88%-68.52%-47.76%-110.7%-131.9%-110.27%-133.05%-129.76%-153.49%-127.34%-166.44%-182.19%-168.65%-121.05%-90.3%
Operating Income Growth %-68.84%-127.44%-78.98%-151.29%-3.51%34.5%27.34%57.14%24.38%29.34%32.68%35.14%24.61%18.19%1.74%-71.48%-94.92%-18.63%-202.83%-186.53%
EBITDA-6.16M-5.94M-4.35M-4.56M-3.74M-2.66M-2.5M-1.79M-3.64M-4.13M-3.49M-4.37M-4.83M-5.89M-5.23M-6.68M-6.48M-7.24M-5.31M-3.87M
EBITDA Margin %-119.84%-155.33%-64.13%-119.35%-124.04%-71.98%-64.74%-44.18%-106.43%-127.31%-105.76%-128.69%-125.23%-149.22%-123.2%-159.68%-177.74%-164.82%-116.81%-85.97%
EBITDA Growth %-64.69%-123.14%-74.07%-154.55%-2.8%35.62%28.42%59.01%24.66%29.84%33.26%34.61%25.43%18.63%1.49%-72.81%-100.59%-19.32%-224.12%-212.61%
D&A (Non-Cash Add-back)454K442K384K306K177K144K146K145K146K149K149K148K175K169K176K283K162K168.23K193K195K
EBIT-6.62M-6.38M-4.73M-4.87M-3.92M-2.81M-2.65M-1.94M-3.79M-4.28M-3.64M-4.52M-5M-4.88M-5.41M-6.96M-6.64M-7.39M-5.5M-4.06M
Net Interest Income000000000-3.3M000-26K-27K-28K027.28K49.34K18.72K
Interest Income0000000000000000031.46K58.82K18.97K
Interest Expense0000000003.3M00026K27K28K04.18K9.49K251
Other Income/Expense-1.14M-572K-666K-148K54K-21K29K6K22K25K1.55M-1.01M3.3M-26K-27K-28K1.31M18.28K50K18K
Pretax Income-7.75M-6.95M-5.4M-5.01M-3.86M-2.83M-2.62M-1.93M-3.76M-4.26M-2.09M-5.53M-1.7M-6.09M-5.43M-6.99M-5.33M-7.39M-5.45M-4.04M
Pretax Margin %-150.77%-181.85%-79.61%-131.23%-128.12%-76.45%-67.77%-47.61%-110.06%-131.13%-63.41%-162.83%-44.15%-154.15%-127.98%-167.11%-146.3%-168.24%-119.95%-89.9%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-7.75M-6.95M-5.4M-5.01M-3.86M-2.83M-2.62M-1.93M-3.76M-4.26M-2.09M-5.53M-1.7M-6.09M-5.43M-6.99M-5.33M-7.39M-5.45M-4.04M
Net Margin %-150.77%-181.85%-79.61%-131.23%-128.12%-76.45%-67.77%-47.61%-110.06%-131.13%-63.41%-162.83%-44.15%-154.15%-127.98%-167.11%-146.3%-168.24%-119.95%-89.9%
Net Income Growth %-100.6%-145.99%-106.42%-159.74%-2.68%33.62%-24.99%65.09%-120.96%30.05%61.48%20.94%68.05%17.64%0.35%-72.94%-56.84%-18.3%-200.74%-185.99%
Net Income (Continuing)-7.75M-6.95M-5.4M-5.01M-3.86M-2.83M-2.62M-1.93M-3.76M-4.26M-2.09M-5.53M-1.7M-6.09M-5.43M-6.99M-5.33M-7.39M-5.45M-4.04M
Discontinued Operations00000000000000000000
Minority Interest129K-60K000000000000000000
EPS (Diluted)-0.52-0.74-0.49-0.55-0.45-0.48-0.40-0.60-1.63-2.32-1.75-4.624.82-7.93-6.43-8.27-4.95-22.00-6.55-4.87
EPS Growth %-15.56%-54.17%-22.5%8.33%72.39%79.31%77.14%87.01%-133.82%70.74%72.78%44.14%197.37%63.95%1.83%-69.82%-6%-94.35%-80.44%-72.08%
EPS (Basic)-0.52-0.74-0.49-0.55-0.45-0.48-0.40-0.60-1.63-2.32-1.75-4.624.82-7.93-6.43-8.27-4.95-22.02-6.55-4.87
Diluted Shares Outstanding14.63M9.29M10.96M9.09M8.6M5.89M6.62M3.23M2.31M1.83M1.2M1.2M990.56K920.48K849.34K849.34K849.34K921.26K833.06K829.52K
Basic Shares Outstanding14.63M9.29M10.96M9.09M8.6M5.89M6.62M3.23M2.31M1.83M1.2M1.2M990.56K920.48K849.34K849.34K849.32K920.48K833.06K829.52K
Dividend Payout Ratio--------------------